Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports enhanced binding affinity and metabolic stability in drug candidates. Commonly employed in the preparation of tyrosine kinase inhibitors, where the chloro-fluoro substitution pattern contributes to selectivity against specific oncogenic targets. Also utilized in agrochemical research for designing bioactive molecules with improved environmental stability.